Clinical trial · Observational
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
NCT04396119CI-TRIAL-00046946completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To explore the topic of lung cancer screening following treatment for Hodgkin lymphoma from the perspective of survivors
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin Lymphoma | Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Explore survivors' attitudes towards lung cancer and lung cancer screening
- timeFrame
- 6 months
- description
- Semi-structured interviews
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Details held in the ADAPT database at The Christie NHS Foundation trust * Responded to most recent ADAPT study questionnaire (April - August 2019) * Aged 18-80 * Previously treated for Hodgkin lymphoma without evidence of relapse for at least 5 years * Able to provide informed consent * Treated with radiotherapy (with lung tissue in the radiotherapy field) and/or alkylating agent containing chemotherapy. Exclusion Criteria: * Previous or current diagnosis of lung cancer * Stated within 2019 health questionnaire that they did not wish to be contacted * Have participated in lung cancer screening through the Manchester Lung Health Checks
References
Publications (0)
Data not yet available
No reference posted for this study.